Recently, our Society was involved in reviewing a Long COVID research protocol. There were several concerns. But one stood out. The study largely treated Long COVID as a single illness, with a single protocol design for all participants, implicitly assuming that all Long COVID patients have similar symptoms, risks, and responses to treatment. That assumption is the problem. Because what we call “Long COVID” is not one condition. It is a catch-all term for a few very different long-term...

Two upcoming research projects, Effect of Semaglutide on ME/CFS Symptoms and Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID , bring hope for improved diagnosis and targeted treatments. Read more about these projects here .

The information below was initially shared on January 9, 2026. In November, researchers at the University of East Anglia announced a blood test that diagnoses ME/CFS with 96% accuracy . Let that sink in! For years, many of you have been told your illness is "all in your head." This test proves what you already knew: ME/CFS has a clear biological signature. It's measurable. It's real. "For the first time, we have a simple blood test that can reliably identify ME/CFS — potentially...